Home |  News |  Events |  Publications |  Contact 
Investor LifeScience Diagnostics Technology Career
Diagnostics » 
Gradipore's Diagnostics Division
Gradipore's Diagnostics Division researches, develops, manufactures and markets reagents used to detect blood-clotting disorders.

The Diagnostics Division has gained international recognition in laboratories which perform blood coagulation tests to predict the risk of thrombosis (blood clotting). Our core products, LA Screen and LA Confirm, focus on detection of Lupus Anticoagulant, a significant cause of recurrent miscarriages and life threatening venous clots.

Gradipore has recently developed other tests that can be used for predicting thrombosis due to genetic abnormalities. The Diagnostics Division is also investigating possible applications for the Gradiflow technology within the diagnostic laboratory.
La venta de los genericos de Cialis como Levitra online en Espana.
What do we make?

  • Specialised clotting assays for the detection of thrombotic risk – Lupus Anticoagulant, Factor V mutation, Protein C Pathway

  • Specialised tests for bleeding disorders – von Willebrand’s disorder

  • Quality control material for these tests

  • Related Events


    Haemostasis News
    Click here to print off the latest issues of our newsletter 'Haemostasis News'

    Cartoons from our 2002 calendar are now available!
    Download a cartoon from our 2002 calendar ' The Evolution of Coagulation Assays'

    Contact Us | Terms of Use | | Terms of Use
    © 2002 Gradipore Limited All rights reserved.